Fujifilm Diosynth Biotechnologies, a global biologics contract development and manufacturing organization (CDMO), has expanded its monoclonal antibody development and manufacturing services with the introduction of its Saturn mAb Platform. The Saturn mAb Platform is the result of the application of years of experience developing and optimizing monoclonal antibodies processes with efficient cGMP production and batch disposition. It is also an extension of Fujifilm Diosynth Biotechnologies’ exp...